Valuation: Bonesupport Holding AB

Market Cap 15.53B 1.55B 1.39B 1.29B 1.17B 2.21B 148B 2.23B 6.08B 76.41B 5.82B 5.69B 246B P/E 2026 *
48.2x
P/E 2027 * 30.7x
Enterprise Value 14.99B 1.49B 1.34B 1.25B 1.13B 2.13B 143B 2.15B 5.87B 73.73B 5.61B 5.49B 237B EV / Sales 2026 *
10x
EV / Sales 2027 * 7.39x
Free-Float
89.54%
Yield 2026 *
0.62%
Yield 2027 * 0.92%
1 day+1.22%
1 week+5.20%
Current month+6.59%
1 month+9.48%
3 months+2.62%
6 months+2.80%
Current year+29.04%
1 week 218.6
Extreme 218.6
243.6
1 month 205.8
Extreme 205.8
243.6
Current year 165
Extreme 165
273.2
1 year 165
Extreme 165
273.2
3 years 110.2
Extreme 110.2
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 2025-08-31
Director of Finance/CFO 63 2018-10-31
Chief Operating Officer 51 2021-11-30
Director TitleAgeSince
Director/Board Member 68 2009-12-31
Chairman 70 2016-12-14
Chairman 71 2019-05-13
Date Insider Type Main position Quantity % Market Cap. Importance
8/28/26 Buy

Public Communications Manager

170 0.0003%
8/26/26 Buy

Director

30 0.0000%
7/20/26 Buy

Chief Executive Officer

1,950 0.0030%
Change 5-day change 1-year change 3-year change Capi.($)
+2.28%+5.20%-8.11%+102.17% 1.55B
+0.28%+3.42%+44.28%+93.65% 1,051B
+0.76%+4.23%+38.10%+68.64% 630B
+1.37%+5.59%+21.85%+89.22% 489B
-0.10%+4.32%+69.86%+40.53% 359B
+0.61%+3.18%+24.10%+42.46% 344B
+0.72%+2.99%+14.79%+34.71% 272B
+0.23%+2.23%-5.49%+8.15% 246B
+0.21%+3.30%+42.36%+46.04% 224B
-0.60%+4.14%+27.41%+96.22% 187B
Average +0.42%+3.23%+26.92%+62.18% 380.53B
Weighted average by Cap. +0.44%+2.93%+34.67%+66.86%

Financials

2026 *2027 *
Net sales 1.5B 149M 133M 124M 113M 213M 14.25B 214M 585M 7.35B 560M 548M 23.67B 1.99B 198M 177M 165M 150M 283M 18.93B 285M 778M 9.77B 744M 728M 31.44B
Net income 319M 31.85M 28.51M 26.58M 24.11M 45.47M 3.04B 45.76M 125M 1.57B 120M 117M 5.06B 506M 50.42M 45.14M 42.08M 38.17M 71.99M 4.82B 72.44M 198M 2.49B 189M 185M 8B
Net Debt -544M -54.2M -48.52M -45.23M -41.02M -77.37M -5.18B -77.86M -213M -2.67B -204M -199M -8.6B -850M -84.71M -75.83M -70.69M -64.12M -121M -8.1B -122M -333M -4.18B -318M -311M -13.45B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
171
Date Price Change Volume
26-10-12 SEK 242.60 +2.28% 232,629
26-10-09 SEK 237.20 +3.04% 286,951
26-10-08 SEK 230.20 +3.60% 359,692
26-10-07 SEK 222.20 -2.20% 307,338
26-10-06 SEK 227.20 -1.47% 403,903
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
237.20SEK
Average target price
356.58SEK
Spread / Average Target
+50.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB
  1. Stock Market
  2. Stocks
  3. BONEX Stock